(Q54456649)
Statements
Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies. (English)
J T Janssen
H Ludwig
W Scheithauer
B E de Pauw
A Keyser
R van Tol
R Flener
1 January 1985
42 Suppl 1
3-6